ArticleHealth science reports2025
Current Status of Cancer Diagnosis and Treatment in Nigeria.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Burden, clinical characteristics, and management patterns of prostate cancer in Nigeria: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- KNOWLEDGE AND PREVALENCE OF THE ADOPTION OF BREAST CANCER SCREENING PRACTICES AMONG FEMALE LAW STUDENTS OF OSUN STATE UNIVERSITY, NIGERIA.Annals of Ibadan postgraduate medicine · 2026Article
- Geographic and demographic patterns of cervical cancer in Africa using GLOBOCAN 2022.BMC cancer · 2026Article
- Clinically actionable pharmacogenomic variants for anticancer therapy in Nigeria: first comprehensive variant profiling in underrepresented Nigerian cohorts.BMC medical genomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cancer has emerged as a leading cause of death worldwide, surpassing HIV/AIDS, tuberculosis, and malaria combined. Nigeria's cases and deaths continue to increase every year due to the high cancer burden that affects the country. There were 269,109 new cancer cases registered in 2022, with breast and prostate cancer being the most prevalent. Despite improvements made, several problems related to the diagnosis and treatment of cancer across the nation remain. This paper reviews these issues while discussing what is being done to establish an efficient system for managing cancer care in Nigeria. Methods: This review utilizes publicly available sources such as GLOBOCAN, Google Scholar, PubMed, and other gray literature. The search was focused on challenges and efforts regarding the diagnosis and treatment of cancers, using Nigeria as one of the main filters. Results: In the review, substantial obstacles to diagnosing and treating cancer in Nigeria included insufficient diagnostic equipment, high out-of-pocket healthcare costs, as well as delayed diagnosis due to the unavailability of health information and service delivery. With only 27 cancer treatment centers available for a population of 218.5 million people, patients encounter delays as well as financial burdens. Efforts have been made, such as establishing cancer centers, launching the Cancer Health Fund, and introducing policies to improve screening and treatment accessibility, like the National Strategic Cancer Control Plan. Also, the Nigerian Sovereign Investment Authority (NSIA) and Lagos University Teaching Hospital (LUTH) Cancer Treatment Centre, from its inauguration in 2019-2024, has treated more than 10,064 patients, providing 8528 radiotherapies, 6733 chemotherapies, and 215 high-dose rate 3D brachytherapy sessions, revitalizing an industry previously unable to adequately address cancer in Nigeria. Conclusion: Nigeria still faces immense challenges in improving cancer diagnosis and treatment. Although recent initiatives are encouraging, enhanced policies and funding are still needed. The provision of more diagnostic services, awareness concerning various types of cancers, and an increase in treatment facilities will be vital to improving cancer care in Nigeria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.